References

Selective vulnerability in α-synucleinopathies

10.1007/s00401-019-02010-2 · 2019 · External reference

The secondary structural difference between Lewy body and glial cytoplasmic inclusion in autopsy brain with synchrotron FTIR micro-spectroscopy

10.1038/s41598-020-76565-6 · 2020 · External reference

QuPath: open source software for digital pathology image analysis

10.1038/s41598-017-17204-5 · 2017 · External reference

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

10.1007/s00401-009-0538-8 · 2009 · External reference

Structural and functional characterization of two alpha-synuclein strains

10.1038/ncomms3575 · 2013 · External reference

Staging of brain pathology related to sporadic Parkinson’s disease

10.1016/s0197-4580(02)00065-9 · 2003 · External reference

Prying into the prion hypothesis for Parkinson’s disease

10.1523/jneurosci.1788-16.2017 · 2017 · External reference

Synthetic α-synuclein fibrils replicate in mice causing MSA-like pathology

10.1038/s41586-025-09698-1 · 2025 · External reference

Expanding the spectrum of neuronal pathology in multiple system atrophy

10.1093/brain/awv114 · 2015 · External reference

Novel self-replicating α-synuclein polymorphs that escape ThT monitoring can spontaneously emerge and acutely spread in neurons

10.1126/sciadv.abc4364 · 2020 · External reference

Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy

10.1186/s40035-019-0164-x · 2019 · External reference

Oligodendrocytes prune axons containing α-synuclein aggregates in vivo: Lewy neurites as precursors of glial cytoplasmic inclusions in multiple system atrophy?

10.3390/biom13020269 · 2023 · External reference

The interplay between α-synuclein and microglia in α-Synucleinopathies

10.3390/ijms24032477 · 2023 · External reference

Unlike twins: an NMR comparison of two α-synuclein polymorphs featuring different toxicity

10.1371/journal.pone.0090659 · 2014 · External reference

Yet another polymorph of α-synuclein: solid-state sequential assignments

10.1007/s12104-013-9526-y · 2014 · External reference

[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy

10.1212/01.wnl.0000078192.95645.e6 · 2003 · External reference

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson’s disease

10.1016/j.nbd.2005.08.002 · 2006 · External reference

Characterization of pSer129-αSyn pathology and neurofilament light-chain release across in vivo, ex vivo, and in vitro models of pre-formed-fibril-induced αSyn aggregation

10.3390/cells13030253 · 2024 · External reference

Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson’s disease brains

10.1007/s00401-003-0766-2 · 2003 · External reference

A novel mouse model for investigating α-synuclein aggregates in oligodendrocytes: implications for the glial cytoplasmic inclusions in multiple system atrophy

10.1186/s13041-024-01104-7 · 2024 · External reference

Glia imaging differentiates multiple system atrophy from Parkinson’s disease: a positron emission tomography study with [11C]PBR28 and machine learning analysis

10.1002/mds.28814 · 2022 · External reference

Overview of general and discriminating markers of differential microglia phenotypes

10.3389/fncel.2020.00198 · 2020 · External reference

Immunohistochemical and molecular investigations show alteration in the inflammatory profile of multiple system atrophy brain

10.1093/jnen/nly035 · 2018 · External reference

Neuropathology and molecular diagnosis of Synucleinopathies

10.1186/s13024-021-00501-z · 2021 · External reference

Transplanted dopaminergic neurons develop PD pathologic changes: a second case report

10.1002/mds.22369 · 2008 · External reference

Widespread microglial activation in multiple system atrophy

10.1002/mds.27620 · 2019 · External reference

Similar neuronal imprint and no cross-seeded fibrils in α-synuclein aggregates from MSA and Parkinson’s disease

10.1038/s41531-021-00264-w · 2022 · External reference

α-Synuclein overexpression increases the tropism of pre-formed fibrils and MSA-patient derived seeds towards oligodendroglia

10.1186/s40478-026-02346-3 · 2026 · External reference

Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging

10.1016/j.parkreldis.2020.11.011 · 2021 · External reference

Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagation

10.1038/nm1746 · 2008 · External reference

Brain microglia activation and peripheral adaptive immunity in Parkinson’s disease: a multimodal PET study

10.1186/s12974-022-02574-z · 2022 · External reference

Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice

10.1007/s00401-022-02425-4 · 2022 · External reference

Seeded assembly in vitro does not replicate the structures of α-synuclein filaments from multiple system atrophy

10.1002/2211-5463.13110 · 2021 · External reference

Molecular and biological compatibility with host alpha-synuclein influences fibril pathogenicity

10.1016/j.celrep.2016.08.053 · 2016 · External reference

Prion-like spreading of pathological α-synuclein in brain

10.1093/brain/awt037 · 2013 · External reference

Microglia in neuroinflammation and neurodegeneration: from understanding to therapy

10.3389/fnins.2021.742065 · 2021 · External reference

⍺-synuclein structural diversity and the cellular environment in ⍺-synuclein transmission models and humans

10.1007/s13311-023-01365-5 · 2023 · External reference

α-Synuclein strains cause distinct synucleinopathies after local and systemic administration

10.1038/nature14547 · 2015 · External reference

Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies

10.1038/s41586-018-0104-4 · 2018 · External reference

Multiple system atrophy

10.1038/s41572-022-00382-6 · 2022 · External reference

MDS clinical diagnostic criteria for Parkinson’s disease

10.1002/mds.26424 · 2015 · External reference

Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism

10.1073/pnas.1514475112 · 2015 · External reference

Neocortical neuronal loss in patients with multiple system atrophy: a stereological study

2017 · External reference

The amyloid packing difference: a pairwise comparison metric for amyloid structures

10.1016/j.str.2026.04.014 · 2026 · External reference

Structures of α-synuclein filaments from multiple system atrophy

10.1038/s41586-020-2317-6 · 2020 · External reference

Structure-function relationship of alpha-synuclein fibrillar polymorphs derived from distinct synucleinopathies

10.1038/s44320-026-00199-5 · 2026 · External reference

Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy

10.1038/s41586-020-1984-7 · 2020 · External reference

Stochastic misfolding drives the emergence of distinct α-synuclein strains

10.1016/j.neuron.2026.01.014 · 2026 · External reference

Phenotypic manifestation of α-synuclein strains derived from Parkinson’s disease and multiple system atrophy in human dopaminergic neurons

10.1038/s41467-021-23682-z · 2021 · External reference

Host oligodendrogliopathy and α-synuclein strains dictate disease severity in multiple system atrophy

10.1093/brain/awac061 · 2023 · External reference

Fibril-seeded animal models of synucleinopathies: pathological mechanisms, disease modeling, and therapeutic implications

10.1016/j.neures.2025.04.008 · 2025 · External reference

Slow progressive accumulation of oligodendroglial alpha-synuclein (a-syn) pathology in synthetic a-syn fibril-induced mouse models of synucleinopathy

10.1093/jnen/nlz070 · 2019 · External reference

The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies

10.1007/s00401-020-02157-3 · 2020 · External reference

Further exploration of the conformational space of α-synuclein fibrils: solid-state NMR assignment of a high-pH polymorph

10.1007/s12104-015-9628-9 · 2016 · External reference

Seed amplification of MSA alpha-synuclein aggregates preserves the biological and structural properties of brain-derived aggregates

2025 · External reference

The Allen mouse brain common coordinate framework: a 3D reference atlas

10.1016/j.cell.2020.04.007 · 2020 · External reference

The Movement Disorder Society criteria for the diagnosis of multiple system atrophy

10.1002/mds.29005 · 2022 · External reference

Refining α-synuclein seed amplification assays to distinguish Parkinson’s disease from multiple system atrophy

10.1186/s40035-025-00469-6 · 2025 · External reference

Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines

10.1007/s00401-019-01959-4 · 2019 · External reference

Beyond strains: molecular diversity in alpha-synuclein at the Center of Disease Heterogeneity

10.3390/ijms241713199 · 2023 · External reference

Parkinson’s disease and multiple system atrophy have distinct -synuclein seed characteristics

10.1074/jbc.ra118.004471 · 2019 · External reference

Structures of α-synuclein filaments from human brains with Lewy pathology

10.1038/s41586-022-05319-3 · 2022 · External reference

Alpha-synuclein fibrils amplified from multiple system atrophy and Parkinson’s disease patient brain spread after intracerebral injection into mouse brain

10.1111/bpa.13196 · 2023 · External reference